
Eris Lifesciences Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Eris Lifesciences Ltd Announces Strategic Partnership with Natco Pharma Ltd for Semaglutide Launch in India".
Filed with NSE · · 3 pages · English

Eris Lifesciences Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Eris Lifesciences Ltd Announces Strategic Partnership with Natco Pharma Ltd for Semaglutide Launch in India".
Follow Eris Lifesciences into a list and get an email when it puts out news.
Follow Eris Lifesciences